| scholarly article | Q13442814 |
| P50 | author | Jing Liang | Q84841480 |
| Yongfeng Shang | Q84841596 | ||
| P2093 | author name string | Yan Wang | |
| Ying Zhang | |||
| Hua Zhang | |||
| Xiaojing Sun | |||
| Luyang Sun | |||
| Ruifang Li | |||
| Wenhua Yu | |||
| Yupeng Chen | |||
| P2860 | cites work | The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome | Q24302180 |
| The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors | Q24304094 | ||
| RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2 | Q24319818 | ||
| TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1 | Q24321891 | ||
| Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 | Q24324556 | ||
| The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily | Q24530578 | ||
| GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors | Q24600501 | ||
| Ligand-induced estrogen receptor alpha degradation by the proteasome: new actors? | Q25257822 | ||
| Sequence and characterization of a coactivator for the steroid hormone receptor superfamily | Q27860465 | ||
| Mechanisms underlying ubiquitination | Q27860656 | ||
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| The ubiquitin system | Q27860803 | ||
| A system for stable expression of short interfering RNAs in mammalian cells | Q27860875 | ||
| The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. | Q27939755 | ||
| The coregulator exchange in transcriptional functions of nuclear receptors | Q28131759 | ||
| Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway | Q73929928 | ||
| The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators | Q74265958 | ||
| An unexpected role for ubiquitylation of a transcriptional activator | Q81589258 | ||
| The F box protein Dsg1/Mdm30 is a transcriptional coactivator that stimulates Gal4 turnover and cotranscriptional mRNA processing | Q81589292 | ||
| Regulation of transcription by a protein methyltransferase | Q28138085 | ||
| Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors | Q28143075 | ||
| Connections and regulation of the human estrogen receptor | Q28201958 | ||
| Combinatorial control of gene expression by nuclear receptors and coregulators | Q28209095 | ||
| Molecular determinants for the tissue specificity of SERMs | Q28211516 | ||
| AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer | Q28245902 | ||
| A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors | Q28246411 | ||
| CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators | Q28594257 | ||
| Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription | Q29547846 | ||
| Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter | Q29616537 | ||
| Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy | Q29619282 | ||
| The proteasome: not just degrading anymore | Q30438604 | ||
| Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins | Q30450954 | ||
| The ubiquitin-proteasome pathway and pathogenesis of human diseases | Q33540242 | ||
| Nuclear receptor cofactors as chromatin remodelers | Q33745092 | ||
| CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome | Q33837034 | ||
| The SRC family of nuclear receptor coactivators | Q33860695 | ||
| The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation | Q33911291 | ||
| The RNA polymerase II elongation complex | Q34188475 | ||
| Ubiquitin enters the new millennium | Q34388963 | ||
| Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. | Q34712217 | ||
| How the ubiquitin-proteasome system controls transcription | Q35075758 | ||
| Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? | Q35606829 | ||
| Expanding functional diversity of the coactivators | Q36064225 | ||
| Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription | Q36110120 | ||
| Differential gene regulation by the SRC family of coactivators | Q36661242 | ||
| Proteasome-dependent degradation of the human estrogen receptor | Q37160826 | ||
| Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling | Q38356127 | ||
| Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways | Q38490337 | ||
| Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells | Q40343980 | ||
| Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus | Q40407591 | ||
| Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells. | Q40429902 | ||
| Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II. | Q40429907 | ||
| Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor | Q40493369 | ||
| cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1. | Q40519257 | ||
| Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators | Q40660685 | ||
| Ubiquitin-dependent degradation of cyclin B is accelerated in polyploid megakaryocytes. | Q41070037 | ||
| FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent | Q43516734 | ||
| Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation | Q44605497 | ||
| Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis | Q46851647 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| P304 | page(s) | 4223-33 | |
| P577 | publication date | 2006-09-20 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription | |
| P478 | volume | 25 |
| Q35907414 | A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein |
| Q34236787 | ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells |
| Q58790020 | BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis |
| Q34121216 | CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen |
| Q55367849 | Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1. |
| Q37264100 | Cks1 enhances transcription efficiency at the GAL1 locus by linking the Paf1 complex to the 19S proteasome |
| Q39958759 | Cotranscriptional splicing potentiates the mRNA production from a subset of estradiol-stimulated genes. |
| Q40026501 | DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression |
| Q36210983 | ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression. |
| Q34520505 | Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription. |
| Q90736751 | Estrogen Receptors and Ubiquitin Proteasome System: Mutual Regulation |
| Q24318938 | GAS, a new glutamate-rich protein, interacts differentially with SRCs and is involved in oestrogen receptor function |
| Q33825397 | Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition |
| Q24315496 | Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells |
| Q34628232 | Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. |
| Q36788865 | Intersection of nuclear receptors and the proteasome on the epigenetic landscape |
| Q37039050 | Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency |
| Q37238734 | JFK, a Kelch domain-containing F-box protein, links the SCF complex to p53 regulation |
| Q35131133 | JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation |
| Q39973068 | Klotho is a target gene of PPAR-gamma. |
| Q40140606 | LMP2-specific inhibitors: chemical genetic tools for proteasome biology |
| Q24308737 | LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer |
| Q35874237 | Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity |
| Q37397989 | MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with β-catenin |
| Q39406924 | MYC Modulation around the CDK2/p27/SKP2 Axis |
| Q37269111 | OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity |
| Q24309768 | Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP |
| Q35619604 | Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy. |
| Q40107103 | Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. |
| Q64082521 | Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation |
| Q35948205 | Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription |
| Q33656037 | Reconciling the concurrent fast and slow cycling of proteins on gene promoters. |
| Q37188091 | Role of proteasomes in cellular regulation |
| Q24339520 | SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities |
| Q24304823 | SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm |
| Q41874295 | SUG-1 plays proteolytic and non-proteolytic roles in the control of retinoic acid target genes via its interaction with SRC-3. |
| Q36975173 | Serial ChIP as a tool to investigate the co-localization or exclusion of proteins on plant genes |
| Q24306404 | Steroid receptor coactivator-interacting protein (SIP) inhibits caspase-independent apoptosis by preventing apoptosis-inducing factor (AIF) from being released from mitochondria |
| Q34575899 | Substrate phosphorylation and feedback regulation in JFK-promoted p53 destabilization |
| Q37295632 | Sumoylation of TCF21 downregulates the transcriptional activity of estrogen receptor-alpha |
| Q39282042 | Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways. |
| Q38248373 | The 26S proteasome and initiation of gene transcription |
| Q33384289 | The UPS: a promising target for breast cancer treatment. |
| Q34799913 | The histone modifications governing TFF1 transcription mediated by estrogen receptor |
| Q24309520 | The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer |
| Q50986605 | UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor. |
| Q36799954 | Ubiquitin and proteasomes in transcription |
| Q35781803 | Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor alpha. |
| Q35148080 | YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt Pathways |
| Q24318720 | ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis |
| Q33825091 | sZIP, an alternative splice variant of ZIP, antagonizes transcription repression and growth inhibition by ZIP |
Search more.